Dynavax, Clover partner for protein-based COVID-19 vaccine

By The Science Advisory Board staff writers

March 25, 2020 -- A new research collaboration between Dynavax Technologies and Clover Biopharmaceuticals aims to develop a vaccine candidate to prevent COVID-19. The partnership, announced on March 24, will advance Clover's vaccine candidate, COVID-19 S-Trimer, with Dynavax providing its technical expertise and CpG 1018, a proprietary toll-like receptor 9 (TLR9) agonist adjuvant.

Using Trimer-Tag technology, Clover began developing the vaccine candidate in late January 2020. The trimer subunit resembles the native trimeric viral spike protein of SARS-CoV-2, which is responsible for binding to host cell surface ACE2 and subsequent viral entry. The trimer is produced via a rapid mammalian cell culture-based expression system developed by Clover.

Dynavax's CpG 1018 is an adjuvant used in Heplisav-B, a hepatitis B vaccine approved by the U.S. Food and Drug Administration. The technology is well-established and has been proven safe, potentially enabling accelerated development and large-scale manufacturing of a COVID-19 vaccine, according to the company.

Frontera supercomputer aids COVID-19 drug development
Scientists are urgently working to build the first complete all-atom model of the SARS-CoV-2 coronavirus envelope, estimated to contain over 200 million...
DOD grant accelerates SARS-CoV-2 vaccine manufacturing
The U.S. Department of Defense (DOD) has awarded Ology Bioservices and Inovio Pharmaceuticals an $11.9 million contract to rapidly manufacture DNA...
New NIH study pinpoints how coronavirus attacks cells
The continued spread of the novel 2019 coronavirus, known as SARS-CoV-2, around the world has raised the need for a test to rapidly and efficiently screen...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
BioProcess International
September 21-24
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter